Filing Details
- Accession Number:
- 0001209191-11-056933
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-17 19:28:55
- Reporting Period:
- 2011-11-15
- Filing Date:
- 2011-11-17
- Accepted Time:
- 2011-11-17 19:28:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103390 | Ardea Biosciences Inc. | RDEA | Pharmaceutical Preparations (2834) | 943200380 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1131146 | Stephen Davis | 4939 Directors Place San Diego CA 92121 | Evp & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-11-15 | 432 | $18.86 | 17,331 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 23, 2010.
- The range of sales prices received was $18.67 to $18.995. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- Includes 576 shares acquired under the Ardea Biosciences, Inc. 2000 Employee Stock Purchase Plan on November 14, 2011.
Billionaire Hedge Funds
